The iPS cell field has had a relatively quiet 2012 so far, but one recent paper has drawn particular attention in the last 10 days. I’m talking about the paper from Jaenisch’s lab on iPS cells in Cell. Quite a few people are excited, but also scratching their heads a bit as to what this […]
Jaenisch’s new, complicated iPS paper in Cell: what the heck does it all mean? Read More »
The Texas Tribune held a liveblog regarding Health & Human Services at festival they were sponsoring. A particularly testy, interesting exchange on stem cells occurred (see starting around 2:51PM) involving Andrea Ferrenz of Celltex and Dr. Leigh Turner of University of Minnesota as well as Texas State Rep. Rick Hardcastle and David Bales of Texans
Stem cell shootout at the Texas Trib Festival including Celltex Read More »
Advanced Cell Technology (ACT; stock symbol ACTC) announced that it has secured $35 million in funding from investment company, Lincoln Park Capital. The press release quotes CEO Gary Rabin: “We are most pleased about this financing agreement, as it has a number of notable benefits for the company,” commented Gary Rabin, chairman and CEO of
Stem Cell Biotech Advanced Cell Technology (ACT) gets $35 million Read More »
Last year, for the second year in a row, I handed out awards to the top players in the stem cell universe. There were the Knoepfler Lab 2011 Stem Cell Awards. If you read that post you can see the full spectrum of the awardees, which included Matt Bohrs for stem cell political cartoon of the
Knoepfler Blog Stem Cell Awards 2012: Real prizes, nominate your favorites! Read More »
I regularly do an update on the publication trends in the iPS cell field and these have been posts that readers have found especially useful. Here was a popular update from 2010 and another one from 2011 that included a who’s who of the iPS cell field more broadly as well beyond just publishing. Then
Part 1 on iPS cell 2012 publication trends: an unusual year Read More »
The NY Times has just run a 3-part, high-profile series on the developing biomedical area of adult stem cell-based tissue regeneration and organ transplant. See picture above (from NY Times) of rat hearts and lungs being “washed” of cells to be used as scaffolds for growing new organs. You can read the three articles here:
Very cool adult stem cell and organ regeneration series in NY Times Read More »
For a while there this weekend, it had seemed that the upcoming adult stem cell meeting in Houston keynoted by Guv Rick Perry had lost something important. Its website! Oops. Now that all seems fixed. Whew. However, a second stem cell-related entity seems to have made the same mistake, but this time it appears likely
Another stem cell website goof: ICMS loses its patient website Read More »
What’s the deal with Nordstrom and stem cells? Are they going to rename themselves “Nordstem”? I grew up in Bellevue, WA, home of the Nordstrom’s family and of the Nordstrom department store chain. I believe the flagship store was just across Lake Washington in Seattle. I don’t like shopping as perhaps most guys feel, but
Nordstrom hawking super expensive, non-FDA approved stem cell cosmetic drugs Read More »
There is enormous interest in point-of-care for-profit stem cell commercialization by relatively small clinics hoping to hit it big here in the U.S. Some big investors have poured millions into these clinics that are treating patients with adult stem cell therapies. As I’ve talked with some of these folks they expect this market to grow dramatically
Surprising main obstacle to point-of-care stem cell commercialization by small clinics Read More »
I think the number of main stream media articles on stem cells that are dumb is increasing…some weeks it’s hard to choose which is the dumbest in fact. This week it is not so hard to pick. The Daily Mail has an epic fail piece on a British company’s dubious stem cell treatment for wrinkles
Dumb stem cell article of the week goes to the Daily Mail on stem cell cosmetics Read More »